ICU Medical Stock Hits New 52-Week High (ICUI)

NEW YORK ( TheStreet) -- ICU Medical (Nasdaq: ICUI) hit a new 52-week high Monday as it is currently trading at $48.93, above its previous 52-week high of $48.26 with 2,107 shares traded as of 9:30 a.m. ET. Average volume has been 57,400 shares over the past 30 days.

ICU Medical has a market cap of $616.2 million and is part of the health care sector and health services industry. Shares are up 7.1% year to date as of the close of trading on Friday.

ICU Medical, Inc. engages in the development, manufacture, and sale of medical technologies used in vascular therapy, oncology, and critical care applications. The company's product line includes custom intravenous (I.V.) systems, closed delivery systems for hazardous drugs, needleless I.V. The company has a P/E ratio of 18.3, above the average health services industry P/E ratio of 17.1 and above the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates ICU Medical as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, attractive valuation levels and compelling growth in net income. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. You can view the full ICU Medical Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.
null

If you liked this article you might like

ICU Medical Wins Big Price Cut to Buy Pfizer's Hospira Unit

These 5 Health Care Stocks Are Breaking Out This Christmas

ICU Medical (ICUI) Stock Closed Higher on $1 Billion Pfizer Deal

Stocks Hold Mixed as Crude Settles Above $50, Wall Street Eyes Jobs Report